Amgen (AMGN) Long-Term Debt Issuances (2009 - 2026)

Amgen has reported Long-Term Debt Issuances for 15 years, with the latest figure at $4.0 billion in Q1 2026.

• On a quarterly basis, Long-Term Debt Issuances rose 1216.94% year-over-year to $4.0 billion in Q1 2026; TTM through Jun 2026 was $4.0 billion, a 375.32% increase from a year earlier, with the FY2025 full-year figure at $683.0 million, up 3.64% from the prior year.
• Long-Term Debt Issuances was $4.0 billion for Q1 2026 at Amgen, up from $81.0 million in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $23.8 billion in Q1 2023, with the low at -$19.0 million in Q4 2022.
• Average Long-Term Debt Issuances over 5 years is $2.9 billion, with a median of $301.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Long-Term Debt Issuances sank 1800.0% in 2022, then surged 24800.0% in 2024.
• Over 5 years, Long-Term Debt Issuances stood at -$19.0 million in 2022, then soared by 21131.58% to $4.0 billion in 2023, then plunged by 93.77% to $249.0 million in 2024, then sank by 67.47% to $81.0 million in 2025, then soared by 4793.83% to $4.0 billion in 2026.
• The last three Long-Term Debt Issuances figures came in at $4.0 billion (Q1 2026), $81.0 million (Q3 2025), and $301.0 million (Q2 2025), per Business Quant data.